Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.
Article
PubMed
Google Scholar
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509–26.
Article
PubMed
CAS
Google Scholar
Kalbaugh CA, Kucharska-Newton A, Wruck L, et al. Peripheral artery disease prevalence and incidence estimated from both outpatient and inpatient settings among medicare fee-for-service beneficiaries in the atherosclerosis risk in communities (ARIC) study. JAHA. 2017;6(5):e003796.
Article
PubMed
PubMed Central
Google Scholar
Heiss C, Pitcher A, Jf Belch J, et al. The year in cardiology: aorta and peripheral circulation. The year in cardiology 2019. Cardiol Croat. 2020;15(7–8):214–27.
Article
Google Scholar
Conte SM, Vale PR. Peripheral arterial disease. Heart Lung Circ. 2018;27(4):427–32.
Article
PubMed
Google Scholar
Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.
Article
PubMed
Google Scholar
Hiatt WR, Armstrong EJ, Larson CJ, et al. Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease. Circ Res. 2015;116(9):1527–39.
Article
PubMed
CAS
Google Scholar
Hamburg NM, Balady GJ. Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation. 2011;123(1):87–97.
Article
PubMed
PubMed Central
Google Scholar
Hicken G, Ameli M. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 1996;12(4):511–2.
Article
PubMed
CAS
Google Scholar
Aboyans V, Ricco J-B, Bartelink M-L, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Kardiol Pol. 2017;75(11):1065–160.
Article
PubMed
Google Scholar
Marchio P, Guerra-Ojeda S, Vila JM, et al. Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxid Med Cell Longev. 2019. https://doi.org/10.1155/2019/8563845.
Article
PubMed
PubMed Central
Google Scholar
Ruparelia N, Choudhury R. Inflammation and atherosclerosis: what is on the horizon? Heart. 2020;106(1):80–5.
Article
PubMed
CAS
Google Scholar
Small AM, Huffman JE, Klarin D, et al. Mendelian randomization analysis of hemostatic factors and their contribution to peripheral artery disease-brief report. Arterioscler Thromb Vasc Biol. 2021;41(1):380–6.
PubMed
CAS
Google Scholar
Meijer WT, Grobbee DE, Hunink MG, et al. Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med. 2000;160(19):2934–8.
Article
PubMed
CAS
Google Scholar
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.
Article
PubMed
PubMed Central
Google Scholar
Xu C, Doi SA. The robust error meta-regression method for dose–response meta-analysis. Int J Evid Based Healthc. 2018;16(3):138–44.
Article
PubMed
Google Scholar
Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4:218–28.
Article
PubMed
CAS
Google Scholar
Aune D, Saugstad OD, Henriksen T, et al. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014;311(15):1536–46.
Article
PubMed
CAS
Google Scholar
Crippa A, Orsini N. Dose-response meta-analysis of differences in means. BMC Med Res Methodol. 2016;16(1):1–10.
Article
Google Scholar
Eller P, Schgoer W, Mueller T, et al. Hepatic lipase polymorphism and increased risk of peripheral arterial disease. J Intern Med. 2005;258(4):344–8.
Article
PubMed
CAS
Google Scholar
Sartori M, Favaretto E, Legnani C, et al. Thrombophilic risk factors and peripheral arterial disease severity. Thromb Haemost. 2010;104(07):71–7.
Article
PubMed
CAS
Google Scholar
Ceasovschih A, Sorodoc V, OnofreiAursulesei V, et al. Biomarker utility for peripheral artery disease diagnosis in real clinical practice: a prospective study. Diagnostics (Basel). 2020;10(9):723.
Article
CAS
Google Scholar
Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19(3):538–45.
Article
PubMed
CAS
Google Scholar
Mlacak B, Blinc A, Pohar M, et al. Peripheral arterial disease and ankle-brachial pressure index as predictors of mortality in residents of Metlika County. Slovenia Croat Med J. 2006;47(2):327–34.
PubMed
Google Scholar
Khandanpour N, Loke YK, Meyer FJ, et al. Homocysteine and peripheral arterial disease: systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2009;38(3):316–22.
Article
PubMed
CAS
Google Scholar
Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA. 1997;277(22):1775–81.
Article
PubMed
CAS
Google Scholar
Kremers B, Wübbeke L, Mees B, et al. Plasma biomarkers to predict cardiovascular outcome in patients with peripheral artery disease: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol. 2020;40(9):2018–32.
Article
PubMed
PubMed Central
CAS
Google Scholar
Voetsch B, Loscalzo J. Genetic determinants of arterial thrombosis. Arterioscler Thromb Vasc Biol. 2004;24(2):216–29.
Article
PubMed
CAS
Google Scholar
Morley RL, Sharma A, Horsch AD, et al. Peripheral artery disease. BMJ. 2018;360:j5842.
Article
PubMed
Google Scholar
Bini A, Fenoglio JJ Jr, Mesa-Tejada R, et al. Identification and distribution of fibrinogen, fibrin, and fibrin (ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis. 1989;9(1):109–21.
Article
PubMed
CAS
Google Scholar
Undas A, Brozek J, Jankowski M, et al. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol. 2006;26(6):1397–404.
Article
PubMed
CAS
Google Scholar
Zaric BL, Obradovic M, Bajic V, et al. Homocysteine and hyperhomocysteinaemia. Curr Med Chem. 2019;26(16):2948–61.
Article
PubMed
CAS
Google Scholar
Coassin S, Kronenberg F. Mechanistic insights into lipoprotein (a): from infamous to ‘inflammous.’ Eur Heart J. 2020;41(24):2272–4.
Article
PubMed
Google Scholar
Boffa MB, Koschinsky ML. Oxidized phospholipids as a unifying theory for lipoprotein (a) and cardiovascular disease. Nat Rev Cardiol. 2019;16(5):305–18.
Article
PubMed
Google Scholar
Van Der Valk FM, Bekkering S, Kroon J, et al. Oxidized phospholipids on lipoprotein (a) elicit arterial wall inflammation and an inflammatory monocyte response in humans. Circulation. 2016;134(8):611–24.
Article
PubMed
PubMed Central
Google Scholar
Liu M, Fan F, Liu B, et al. Joint effects of plasma homocysteine concentration and traditional cardiovascular risk factors on the risk of new-onset peripheral arterial disease. Diabetes Metab Syndr Obes. 2020;13:3383.
Article
PubMed
PubMed Central
CAS
Google Scholar
Rong D, Liu J, Jia X, et al. Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population. Atherosclerosis. 2017;263:205–10.
Article
PubMed
PubMed Central
CAS
Google Scholar
Forbang NI, Criqui MH, Allison MA, et al. Sex and ethnic differences in the associations between lipoprotein (a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis. J Vasc Surg. 2016;63(2):453–8.
Article
PubMed
Google Scholar
Mueller T, Marschon R, Dieplinger B, et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg. 2005;41(5):808–15.
Article
PubMed
Google Scholar
Weragoda J, Seneviratne R, Weerasinghe MC, et al. Risk factors of peripheral arterial disease: a case control study in Sri Lanka. BMC Res Notes. 2016;9(1):1–8.
Article
Google Scholar
Bertoia ML, Pai JK, Cooke JP, et al. Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. Atherosclerosis. 2014;235(1):94–101.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mohamad T, Veeranna V, Shenoy M, et al. Predictors of combined peripheral arterial disease and coronary artery disease in a population cohort representative of the current us population (sub-analysis of nhanes study). J Am Coll Cardiol. 2011;57(14S):E1499–E1499.
Article
Google Scholar
Sabino A, Fernandes AP, Lima LM, et al. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease. J Thromb Thrombolysis. 2009;27(1):82–7.
Article
PubMed
CAS
Google Scholar
Garofolo L, Barros N Jr, Miranda F Jr, et al. Association of increased levels of homocysteine and peripheral arterial disease in a Japanese-Brazilian population. Eur J Vasc Endovasc Surg. 2007;34(1):23–8.
Article
PubMed
CAS
Google Scholar
Guallar E, Silbergeld EK, Navas-Acien A, et al. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium, and renal function. Am J Epidemiol. 2006;163(8):700–8.
Article
PubMed
Google Scholar
Allison MA, Criqui MH, Mcclelland RL, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;48(6):1190–7.
Article
PubMed
Google Scholar
Mueller T, Dieplinger B, Gegenhuber A, et al. Serum total 8-iso-prostaglandin F2α: a new and independent predictor of peripheral arterial disease. J Vasc Surg. 2004;40(4):768–73.
Article
PubMed
CAS
Google Scholar
Van Den Bosch MA, Bloemenkamp DG, Willem PTM, et al. Hyperhomocysteinemia and risk for peripheral arterial occlusive disease in young women. J Vasc Surg. 2003;38(4):772–8.
Article
PubMed
Google Scholar
Bloemenkamp DG, Van Den Bosch MA, Mali WP, et al. Novel risk factors for peripheral arterial disease in young women. Am J Med. 2002;113(6):462–7.
Article
PubMed
Google Scholar
Bloemenkamp D, Mali WTM, Tanis B, et al. The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration. Eur J Clin Invest. 2002;32(8):549–55.
Article
PubMed
CAS
Google Scholar
Stricker H, Soldati G, Balmelli T, et al. Homocysteine, vitamins and gene mutations in peripheral arterial disease. Blood Coag Fibrinol. 2001;12(6):469–75.
Article
CAS
Google Scholar
Loncar R, Hrboka V, Tabakovic-Loncar V, et al. Screening of plasma homocysteine in peripheral arterial disease. Ann Med. 2001;33(1):48–54.
Article
PubMed
CAS
Google Scholar
Bunout D, Petermann M, Hirsch S, et al. Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. Nutrition. 2000;16(6):434–8.
Article
PubMed
CAS
Google Scholar
Todesco L, Angst C, Litynski P, et al. Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur J Clin Invest. 1999;29(12):1003–9.
Article
PubMed
CAS
Google Scholar
Aronow WS, Ahn C. Association between plasma homocysteine and peripheral arterial disease in older persons. Coron Artery Dis. 1998;9(1):49–50.
Article
PubMed
CAS
Google Scholar
Malinow M, Kang S, Taylor L, et al. Prevalence of hyperhomocyst (e) inemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79(6):1180–8.
Article
PubMed
CAS
Google Scholar
Taylor LM Jr, Defrang RD, Harris EJ Jr, et al. The association of elevated plasma homocyst (e) ine with progression of symptomatic peripheral arterial disease. J Vasc Surg. 1991;13(1):128–36.
Article
PubMed
Google Scholar
Celebi S, Berkalp B, Amasyali B. The association between thrombotic and inflammatory biomarkers and lower-extremity peripheral artery disease. Int Wound J. 2020;17(5):1346–55.
Article
PubMed
PubMed Central
Google Scholar
Mancho CR, Martinez-Aguilar E, Gomez-Rodriguez V, et al. C0162: procoagulant phospolipid activity in microparticles is associated to cardiovascular risk factors and disease severity in peripheral artery disease. Thromb Res. 2014;133:S94.
Article
Google Scholar
Grenon SM, Cohen BE, Smolderen K, et al. Peripheral arterial disease, gender, and depression in the Heart and Soul Study. J Vasc Surg. 2014;60(2):396–403.
Article
PubMed
PubMed Central
Google Scholar
Undas A, Nowakowski T, Ciesla-Dul M, et al. Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans. Atherosclerosis. 2011;215(2):481–6.
Article
PubMed
CAS
Google Scholar
De Bruijne EL, Gils A, Rijken DC, et al. High thrombin activatable fibrinolysis inhibitor levels are associated with an increased risk of premature peripheral arterial disease. Thromb Res. 2011;127(3):254–8.
Article
PubMed
Google Scholar
Reich LM, Heiss G, Boland LL, et al. Ankle—brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort. Vasc Med. 2007;12(4):267–73.
Article
PubMed
Google Scholar
Mangiafico RA, Sarnataro F, Mangiafico M, et al. Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing. 2006;35(1):60–5.
Article
PubMed
Google Scholar
Kaperonis E, Liapis C, Kakisis J, et al. Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2006;31(5):509–15.
Article
PubMed
CAS
Google Scholar
Wildman RP, Muntner P, Chen J, et al. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999–2002. Am J Cardiol. 2005;96(11):1579–83.
Article
PubMed
Google Scholar
Nasir K, Guallar E, Navas-Acien A, et al. Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999–2002. Arterioscler Thromb Vasc Biol. 2005;25(9):1966–71.
Article
PubMed
CAS
Google Scholar
Bozkurt AK, Koksal C, Ercan M. The altered hemorheologic parameters in thromboangiitis obliterans: a new insight. Clin Appl Thromb Hemost. 2004;10(1):45–50.
Article
PubMed
Google Scholar
Smith FB, Connor JM, Lee AJ, et al. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+ 1689 polymorphisms with peripheral arterial disease and ischaemic heart disease. Thromb Res. 2003;112(4):209–16.
Article
PubMed
CAS
Google Scholar
Makin AJ, Chung NA, Silverman SH, et al. Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease: Relationship to ethnicity and disease severity. Thromb Res. 2003;111(4–5):221–6.
Article
PubMed
CAS
Google Scholar
Giunta R, Coppola A, Luongo C, et al. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol. 2001;80(12):745–8.
Article
PubMed
CAS
Google Scholar
Blann A, Bignell A, Mccollum C. von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. Atherosclerosis. 1998;139(2):317–22.
Article
PubMed
CAS
Google Scholar
Poredoš P, Žižek B. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease. Angiology. 1996;47(3):253–9.
Article
PubMed
Google Scholar
Herren T, Stricker H, Haeberli A, et al. Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation. 1994;90(6):2679–86.
Article
PubMed
CAS
Google Scholar
Fabsitz R, Sidawy A, Go O, et al. Prevalence of peripheral arterial disease and associated risk factors in American Indians: the Strong Heart Study. Am J Epidemiol. 1999;149(4):330–8.
Article
PubMed
CAS
Google Scholar
Okraska-Bylica A, Wilkosz T, Słowik L, et al. Altered fibrin clot properties in patients with premature peripheral artery disease. Pol Arch Intern Med. 2012. https://doi.org/10.20452/pamw.1535.
Article
Google Scholar
Li S-B, Yang F, Jing L, et al. Correlation between plasma lipoprotein-associated phospholipase A2 and peripheral arterial disease. Exp Ther Med. 2013;5(5):1451–5.
Article
PubMed
PubMed Central
CAS
Google Scholar
Leng G, Lee A, Fowkes F, et al. The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease: the Edinburgh Artery Study. Eur Heart J. 1995;16(11):1542–8.
Article
PubMed
CAS
Google Scholar
Mustonen P, LepaNtalo M, Lassila R. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis. ATVB. 1998;18(2):244–9.
Article
CAS
Google Scholar
Kheirkhah A, Lamina C, Rantner B, et al. Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study. Atherosclerosis. 2021;316:41–7.
Article
PubMed
CAS
Google Scholar
Tunstall-Pedoe H, Peters SA, Woodward M, et al. Twenty-year predictors of peripheral arterial disease compared with coronary heart disease in the Scottish Heart Health Extended Cohort (SHHEC). J Am Heart Assoc. 2017;6(9): e005967.
Article
PubMed
PubMed Central
Google Scholar
Tmoyan N, Ezhov M, Afanasieva O, et al. Lipoprotein (a) is a marker of peripheral artery disease in the absence of coronary heart disease: P1411. Eur Heart J. 2017. https://doi.org/10.1093/eurheartj/ehx502.P1411.
Article
Google Scholar
Laschkolnig A, Kollerits B, Lamina C, et al. Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts. Cardiovasc Res. 2014;103(1):28–36.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ye Z, Ali Z, Klee GG, et al. Associations of candidate biomarkers of vascular disease with the ankle–brachial index and peripheral arterial disease. Am J Hypertens. 2013;26(4):495–502.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bertoia ML, Pai JK, Lee J-H, et al. Oxidation-specific biomarkers and risk of peripheral artery disease. J Am Coll Cardiol. 2013;61(21):2169–79.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bérard AM, Bedel A, Le Trequesser R, et al. Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study. PLoS ONE. 2013;8(3): e37882.
Article
PubMed
PubMed Central
Google Scholar
Gurdasani D, Sjouke B, Tsimikas S, et al. Lipoprotein (a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol. 2012;32(12):3058–65.
Article
PubMed
PubMed Central
CAS
Google Scholar
Volpato S, Vigna GB, Mcdermott MM, et al. Lipoprotein (a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol. 2010;105(12):1825–30.
Article
PubMed
PubMed Central
CAS
Google Scholar
Pradhan AD, Shrivastava S, Cook NR, et al. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation. 2008;117(6):823–31.
Article
PubMed
Google Scholar
Ix JH, Allison MA, Denenberg JO, et al. Novel cardiovascular risk factors do not completely explain the higher prevalence of peripheral arterial disease among African Americans: the San Diego Population Study. J Am Coll Cardiol. 2008;51(24):2347–54.
Article
PubMed
Google Scholar
Dieplinger B, Lingenhel A, Baumgartner N, et al. Increased serum lipoprotein (a) concentrations and low molecular weight phenotypes of apolipoprotein (a) are associated with symptomatic peripheral arterial disease. Clin Chem. 2007;53(7):1298–305.
Article
PubMed
CAS
Google Scholar
Vigna G, Volpato S, Zuliani G, et al. Th-P15: 171 Lipoprotein (A) and peripheral arterial disease by ankle/brachial index: data from the Inchianti study. Atherosclerosis. 2006;3(7):530.
Article
Google Scholar
Sofi F, Lari B, Rogolino A, et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg. 2005;41(2):255–60.
Article
PubMed
Google Scholar
Diehm C, Lange S, Trampisch HJ, et al. Relationship between lipid parameters and the presence of peripheral arterial disease in elderly patients. Curr Med Res Opin. 2004;20(12):1873–5.
Article
PubMed
Google Scholar
Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481–5.
Article
PubMed
CAS
Google Scholar
Sutton-Tyrrell K, Evans RW, Meilahn E, et al. Lipoprotein (a) and peripheral atherosclerosis in older adults. Atherosclerosis. 1996;122(1):11–9.
Article
PubMed
CAS
Google Scholar
Trinder M, Uddin MM, Finneran P, et al. Clinical utility of lipoprotein (a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease. JAMA cardiology. 2021;6(3):287–95.
Article
Google Scholar